NEW YORK, Dec. 30 (GenomeWeb News) - Transgenomic's board of directors has voted to "either sell or liquidate" its nucleic acids operating segment, the company said in an SEC filing yesterday.
Registering provides access to this and other free content.
Already have an account?Login Now.
NPR reports that Turkish high school students will no longer study evolution.
Researchers report they sequenced and identified plant species in an "al fresco" laboratory.
An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.
In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.